Syros Pharmaceuticals Total Liabilities (Quarterly) Trends

Syros Pharmaceuticals Inc (SYRS)

5.04 -0.06 (-1.18%) USD | NASDAQ | Apr 26, 16:00

5.04 0.00 (0.00%) After-Hours: 20:00

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	151.51M
September 30, 2023	111.49M
June 30, 2023	107.74M
March 31, 2023	98.57M
December 31, 2022	116.75M
September 30, 2022	155.55M
June 30, 2022	95.22M
March 31, 2022	89.34M
December 31, 2021	97.72M
September 30, 2021	101.98M
June 30, 2021	103.76M
March 31, 2021	110.75M
December 31, 2020	122.70M
September 30, 2020	87.40M
June 30, 2020	85.41M
March 31, 2020	84.86M
December 31, 2019	70.79M

Date	Value
September 30, 2019	49.26M
June 30, 2019	39.91M
March 31, 2019	24.41M
December 31, 2018	28.18M
September 30, 2018	25.80M
June 30, 2018	22.67M
March 31, 2018	23.60M
December 31, 2017	13.16M
September 30, 2017	10.08M
June 30, 2017	7.95M
March 31, 2017	7.887M
December 31, 2016	10.72M
September 30, 2016	9.629M
June 30, 2016	7.552M
March 31, 2016	6.908M
December 31, 2015	9.582M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

39.91M

Minimum

Jun 2019

155.55M

Maximum

Sep 2022

98.98M

Average

98.57M

Median

Mar 2023

Total Liabilities (Quarterly) Benchmarks

PDS Biotechnology Corp	33.26M
PAVmed Inc	57.14M
Moderna Inc	4.572B
Altimmune Inc	16.54M
iBio Inc	24.82M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly)	168.17M
Shareholders Equity (Quarterly)	16.66M
Debt to Equity Ratio	2.474
Current Ratio	3.952
Net Debt Paydown Yield	-0.07%